4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide

C100H86F10N40O6 — CID 161248881

IUPAC4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide
SMILESCOc1cccc(-c2nnc3ccc(NC4CC4)nn23)c1.COc1ccccc1-c1nnc2ccc(NC3CC3)nn12.N#Cc1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1.NC(=O)CNc1ccc2nnc(-c3ccc(C(F)(F)F)cc3)n2n1.NC(=O)CNc1ccc2nnc(-c3cccc(C(F)(F)F)c3)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3C(F)(F)F)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3F)n2n1
InChIInChI=1S/C15H12N6.2C15H15N5O.3C14H11F3N6O.C13H11FN6O/c16-9-10-1-3-11(4-2-10)15-19-18-14-8-7-13(20-21(14)15)17-12-5-6-12;1-21-12-4-2-3-10(9-12)15-18-17-14-8-7-13(19-20(14)15)16-11-5-6-11;1-21-12-5-3-2-4-11(12)15-18-17-14-9-8-13(19-20(14)15)16-10-6-7-10;15-14(16,17)9-3-1-8(2-4-9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-3-1-2-8(6-9)13-21-20-12-5-4-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-4-2-1-3-8(9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;14-9-4-2-1-3-8(9)13-18-17-12-6-5-11(19-20(12)13)16-7-10(15)21/h1-4,7-8,12H,5-6H2,(H,17,20);2-4,7-9,11H,5-6H2,1H3,(H,16,19);2-5,8-10H,6-7H2,1H3,(H,16,19);3*1-6H,7H2,(H2,18,24)(H,19,22);1-6H,7H2,(H2,15,21)(H,16,19)
InChIKeyVAZSCMPAEYYGGJ-UHFFFAOYSA-N
MW2134.04 g/mol
LogP12.94
Rot. Bonds27

About 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide

4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide (PubChem CID 161248881) has the molecular formula C100H86F10N40O6 and a molecular weight of 2134.04 g/mol. Its IUPAC name is 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide.

Molecular Properties

Compound Name4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide
PubChem CID161248881
Molecular FormulaC100H86F10N40O6
Molecular Weight2134.04 g/mol
Exact Mass2132.75
IUPAC Name4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide
SMILESCOc1cccc(-c2nnc3ccc(NC4CC4)nn23)c1.COc1ccccc1-c1nnc2ccc(NC3CC3)nn12.N#Cc1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1.NC(=O)CNc1ccc2nnc(-c3ccc(C(F)(F)F)cc3)n2n1.NC(=O)CNc1ccc2nnc(-c3cccc(C(F)(F)F)c3)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3C(F)(F)F)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3F)n2n1
InChIInChI=1S/C15H12N6.2C15H15N5O.3C14H11F3N6O.C13H11FN6O/c16-9-10-1-3-11(4-2-10)15-19-18-14-8-7-13(20-21(14)15)17-12-5-6-12;1-21-12-4-2-3-10(9-12)15-18-17-14-8-7-13(19-20(14)15)16-11-5-6-11;1-21-12-5-3-2-4-11(12)15-18-17-14-9-8-13(19-20(14)15)16-10-6-7-10;15-14(16,17)9-3-1-8(2-4-9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-3-1-2-8(6-9)13-21-20-12-5-4-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-4-2-1-3-8(9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;14-9-4-2-1-3-8(9)13-18-17-12-6-5-11(19-20(12)13)16-7-10(15)21/h1-4,7-8,12H,5-6H2,(H,17,20);2-4,7-9,11H,5-6H2,1H3,(H,16,19);2-5,8-10H,6-7H2,1H3,(H,16,19);3*1-6H,7H2,(H2,18,24)(H,19,22);1-6H,7H2,(H2,15,21)(H,16,19)
InChIKeyVAZSCMPAEYYGGJ-UHFFFAOYSA-N
XLogP12.94
TPSA600.38 Ų
H-Bond Donors11
H-Bond Acceptors42
Rotatable Bonds27
Heavy Atoms156
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002134.04
LogP ≤ 512.94
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1042

Analyze 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide?
The IUPAC name of 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide (CID 161248881) is 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide.
What is the SMILES notation for 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide?
The canonical SMILES for 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide is COc1cccc(-c2nnc3ccc(NC4CC4)nn23)c1.COc1ccccc1-c1nnc2ccc(NC3CC3)nn12.N#Cc1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1.NC(=O)CNc1ccc2nnc(-c3ccc(C(F)(F)F)cc3)n2n1.NC(=O)CNc1ccc2nnc(-c3cccc(C(F)(F)F)c3)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3C(F)(F)F)n2n1.NC(=O)CNc1ccc2nnc(-c3ccccc3F)n2n1.
What is the InChIKey of 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide?
The InChIKey is VAZSCMPAEYYGGJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H12N6.2C15H15N5O.3C14H11F3N6O.C13H11FN6O/c16-9-10-1-3-11(4-2-10)15-19-18-14-8-7-13(20-21(14)15)17-12-5-6-12;1-21-12-4-2-3-10(9-12)15-18-17-14-8-7-13(19-20(14)15)16-11-5-6-11;1-21-12-5-3-2-4-11(12)15-18-17-14-9-8-13(19-20(14)15)16-10-6-7-10;15-14(16,17)9-3-1-8(2-4-9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-3-1-2-8(6-9)13-21-20-12-5-4-11(22-23(12)13)19-7-10(18)24;15-14(16,17)9-4-2-1-3-8(9)13-21-20-12-6-5-11(22-23(12)13)19-7-10(18)24;14-9-4-2-1-3-8(9)13-18-17-12-6-5-11(19-20(12)13)16-7-10(15)21/h1-4,7-8,12H,5-6H2,(H,17,20);2-4,7-9,11H,5-6H2,1H3,(H,16,19);2-5,8-10H,6-7H2,1H3,(H,16,19);3*1-6H,7H2,(H2,18,24)(H,19,22);1-6H,7H2,(H2,15,21)(H,16,19).
What are the key properties of 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide?
4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide has a molecular weight of 2134.04 g/mol, XLogP of 12.94, 27 rotatable bonds, 11 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-(cyclopropylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]benzonitrile;N-cyclopropyl-3-(2-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;N-cyclopropyl-3-(3-methoxyphenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-amine;2-[[3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide;2-[[3-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]amino]acetamide is sourced from PubChem (CID 161248881), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).